Analyst Price Target is C$6.67
▲ +17.79% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Aurora Cannabis in the last 3 months. The average price target is C$6.67, with a high forecast of C$8.00 and a low forecast of C$5.00. The average price target represents a 17.79% upside from the last price of C$5.66.
Current Consensus is
Moderate Buy
The current consensus among 3 polled investment analysts is to moderate buy stock in Aurora Cannabis. This rating has held steady since August 2026, when it changed from a Buy consensus rating.
Aurora is Opening the World to Cannabis ¿, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Drift , San Raf , Daily Special ¿, Tasty's ¿, Being and Greybeard . Medical cannabis brands include MedReleaf , CanniMed , Aurora and Whistler Medical Marijuana Corporation , as well as international brands, Pedanios , IndiMed ¿ and CraftPlant ¿. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched.
Read More